Stockreport

Plus Therapeutics to Participate in Upcoming January Conferences

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, [Read more]